The USPSTF reports that evidence is insufficient to recommend for or against screening children or adolescents for prediabetes or T2D. These findings form the basis of a final recommendation statement published in the Journal of the American Medical Association. Daniel E. Jonas, MD, MPH, and colleagues reviewed the evidence on the benefits and harms of screening children and adolescents for prediabetes and T2D from eight publications with 856 participants. None of the studies directly examined the benefits or harms of screening. Based on these findings, the USPSTF concluded that the evidence is insufficient for assessing the benefits and harms of T2D screening in children and adolescents. “The rate of prediabetes and T2D in youth is increasing,” a task force member said in a statement. “It is important that healthcare professionals be aware of the signs and symptoms of prediabetes and T2D and use their judgment when determining whether or not to screen youth.”
